Home/Filings/4/0001209191-21-046027
4//SEC Filing

Hardie Robert D. 4

Accession 0001209191-21-046027

CIK 0001576885other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 6:14 PM ET

Size

14.9 KB

Accession

0001209191-21-046027

Insider Transaction Report

Form 4
Period: 2021-07-06
Transactions
  • Conversion

    Common Stock

    2021-07-06+2,076,3263,201,156 total(indirect: See footnotes)
  • Purchase

    Common Stock

    2021-07-06$16.00/sh+750,000$12,000,0003,951,156 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2021-07-062,076,3260 total(indirect: See footnote)
    Common Stock (2,076,326 underlying)
  • Conversion

    Common Stock

    2021-07-06+1,124,8301,124,830 total(indirect: See footnote)
  • Conversion

    Series A-1 Preferred Stock

    2021-07-061,124,8300 total(indirect: See footnote)
    Common Stock (1,124,830 underlying)
Footnotes (4)
  • [F1]On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  • [F2]Consists of 562,415 shares of common stock issuable upon conversion of Series A-1 preferred stock held by H7 Holdings LLC, and 562,415 shares of common stock issuable upon conversion of Series A-1 preferred stock held by Level One Partners, LLC. Robert D. Hardie is the Manager of both H7 Holdings, LLC and Level One Partners, LLC and has the power to vote or dispose of the shares held by each entity. The Reporting Person disclaims beneficial ownership of the shares held by H7 Holdings, LLC and Level One Partners, LLC, except to the extent of his pecuniary interest therein.
  • [F3]Consists of 1,038,163 shares of common stock issuable upon conversion of Series B convertible preferred stock held by H7 Holdings LLC, and 1,038,163 shares of common stock issuable upon conversion of Series B convertible preferred stock held by Level One Partners, LLC. Robert D. Hardie is the Manager of both H7 Holdings, LLC and Level One Partners, LLC and has the power to vote or dispose of the shares held by each entity. The Reporting Person disclaims beneficial ownership of the shares held by H7 Holdings, LLC and Level One Partners, LLC, except to the extent of his pecuniary interest therein.
  • [F4]Consists of 375,000 shares of common stock held by H7 Holdings LLC, and 375,000 shares of common stock held by Level One Partners, LLC. Robert D. Hardie is the Manager of both H7 Holdings, LLC and Level One Partners, LLC and has the power to vote or dispose of the shares held by each entity. The Reporting Person disclaims beneficial ownership of the shares held by H7 Holdings, LLC and Level One Partners, LLC, except to the extent of his pecuniary interest therein.

Issuer

Acumen Pharmaceuticals, Inc.

CIK 0001576885

Entity typeother

Related Parties

1
  • filerCIK 0001804350

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 6:14 PM ET
Size
14.9 KB